Guy Lerebours

5.9k total citations · 2 hit papers
27 papers, 4.3k citations indexed

About

Guy Lerebours is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Guy Lerebours has authored 27 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Guy Lerebours's work include Heart Rate Variability and Autonomic Control (9 papers), Heart rate and cardiovascular health (8 papers) and Blood Pressure and Hypertension Studies (6 papers). Guy Lerebours is often cited by papers focused on Heart Rate Variability and Autonomic Control (9 papers), Heart rate and cardiovascular health (8 papers) and Blood Pressure and Hypertension Studies (6 papers). Guy Lerebours collaborates with scholars based in France, United Kingdom and United States. Guy Lerebours's co-authors include Jeffrey Borer, Michel Komajda, Ian Ford, Karl Swedberg, Michael Böhm, Luigi Tavazzi, Kim Fox, Patrice Jaillon, Isabelle Antony and A Nitenberg and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Guy Lerebours

27 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

2010 1.7k citations Karl Swedberg, Michel Komajda et al. The Lancet profile →
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

2010 822 citations Michael Böhm, Karl Swedberg et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy Lerebours France	17	3.7k	498	305	283	247	27	4.3k
Bert Andersson Sweden	32	2.6k 0.7×	415 0.8×	585 1.9×	259 0.9×	238 1.0×	100	3.5k
H. Pouleur Belgium	34	3.3k 0.9×	423 0.8×	491 1.6×	283 1.0×	310 1.3×	150	3.9k
Isaac Kobrin United States	28	2.3k 0.6×	346 0.7×	277 0.9×	319 1.1×	422 1.7×	100	2.9k
Steven Singh United States	32	5.2k 1.4×	324 0.7×	513 1.7×	238 0.8×	283 1.1×	112	5.7k
H. J. Dargie United Kingdom	17	1.8k 0.5×	289 0.6×	328 1.1×	215 0.8×	226 0.9×	38	2.5k
Peter E. Pool United States	26	1.7k 0.5×	483 1.0×	305 1.0×	240 0.8×	221 0.9×	57	2.5k
PA Poole-Wilson United Kingdom	19	1.8k 0.5×	639 1.3×	226 0.7×	116 0.4×	294 1.2×	50	2.6k
Ian Crozier New Zealand	34	4.0k 1.1×	321 0.6×	722 2.4×	301 1.1×	168 0.7×	141	4.6k
David Collier United Kingdom	28	2.1k 0.6×	385 0.8×	602 2.0×	532 1.9×	288 1.2×	82	3.6k
James D. Marsh United States	28	1.9k 0.5×	1.1k 2.2×	278 0.9×	173 0.6×	224 0.9×	56	2.9k

Countries citing papers authored by Guy Lerebours

Since Specialization

Citations

This map shows the geographic impact of Guy Lerebours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Lerebours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Lerebours more than expected).

Fields of papers citing papers by Guy Lerebours

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Lerebours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Lerebours. The network helps show where Guy Lerebours may publish in the future.

Co-authorship network of co-authors of Guy Lerebours

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Lerebours. A scholar is included among the top collaborators of Guy Lerebours based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Lerebours. Guy Lerebours is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Canet, Emmanuel, Guy Lerebours, & Jean‐Paul Vilaine. (2011). Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine. Annals of the New York Academy of Sciences. 1222(1). 90–99. 17 indexed citations

Swedberg, Karl, Michel Komajda, Michael Böhm, et al.. (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 376(9744). 875–885. 1708 indexed citations breakdown →

Böhm, Michael, Karl Swedberg, Michel Komajda, et al.. (2010). Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. The Lancet. 376(9744). 886–894. 822 indexed citations breakdown →

Lerebours, Guy. (2007). Le rythme sinusal. médecine/sciences. 23(6-7). 657–662. 2 indexed citations

Duboc, Denis, Christophe Meune, Guy Lerebours, et al.. (2005). Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. Journal of the American College of Cardiology. 45(6). 855–857. 294 indexed citations

Joannidès, Robinson, Nicholas Moore, Patricia Compagnon, et al.. (2005). Comparative effects of ivabradine, a selective heart rate‐lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. British Journal of Clinical Pharmacology. 61(2). 127–137. 65 indexed citations

Borer, Jeffrey, Kim Fox, Patrice Jaillon, & Guy Lerebours. (2003). Antianginal and Antiischemic Effects of Ivabradine, an I _f Inhibitor, in Stable Angina. Circulation. 107(6). 817–823. 349 indexed citations

Varin, R., Paul Mulder, Fabienne Tamion, et al.. (2000). Improvement of Endothelial Function by Chronic Angiotensin-Converting Enzyme Inhibition in Heart Failure. Circulation. 102(3). 351–356. 134 indexed citations

Antony, Isabelle, D. S. Chemla, Guy Lerebours, & A Nitenberg. (2000). Restoration of Flow-Dependent Coronary Dilation by ACE Inhibition Improves Papaverine-Induced Maximal Coronary Blood Flow in Hypertensive Patients: Demonstration That Large Epicardial Coronary Arteries are More Than Conductance Vessels. Journal of Cardiovascular Pharmacology. 36(5). 570–576. 1 indexed citations

10.

Lecarpentier, Yves, Catherine Coirault, Guy Lerebours, et al.. (1997). Effects of Angiotensin Converting Enzyme Inhibition on Crossbridge Properties of Diaphragm in Cardiomyopathic Hamsters of the Dilated BIO 53-58 Strain. American Journal of Respiratory and Critical Care Medicine. 155(2). 630–636. 32 indexed citations

11.

Antony, Isabelle, Guy Lerebours, & A Nitenberg. (1996). Angiotensin-Converting Enzyme Inhibition Restores Flow-Dependent and Cold Pressor Test–Induced Dilations in Coronary Arteries of Hypertensive Patients. Circulation. 94(12). 3115–3122. 102 indexed citations

12.

Alcocer, Luis, et al.. (1995). Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril. Cardiovascular Drugs and Therapy. 9(3). 431–436. 9 indexed citations

13.

Antony, Isabelle, Guy Lerebours, & A Nitenberg. (1995). Loss of Flow-Dependent Coronary Artery Dilatation in Patients With Hypertension. Circulation. 91(6). 1624–1628. 68 indexed citations

14.

Chemla, D. S., Elizabeth Scalbert, Pierre Desché, et al.. (1994). Effects of Early and Late Therapy with Perindopril on Survival and Myocardial Inotropic State in Experimental Dilated Cardiomyopathy. Journal of Cardiovascular Pharmacology. 24(1). 151–157. 7 indexed citations

15.

Lerebours, Guy & Isabelle Antony. (1994). Clinical review of perindopril in the treatment of hypertension.. PubMed. 10 Suppl D. 3D–7D. 2 indexed citations

16.

Desché, Pierre, et al.. (1993). Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. The American Journal of Cardiology. 71(17). E61–E68. 11 indexed citations

17.

Lerebours, Guy, et al.. (1993). Vitamin A supplementation and increased prevalence of childhood diarrhoea and acute respiratory infections. The Lancet. 342(8871). 578–582. 95 indexed citations

18.

Bonmarchand, G., et al.. (1989). Penetration of pefloxacin into bronchial secretions. Antimicrobial Agents and Chemotherapy. 33(3). 391–393. 6 indexed citations

19.

Frébourg, Thierry, Guy Lerebours, Bertrand Delpech, et al.. (1987). Serum hyaluronate in malignant pleural mesothelioma. Cancer. 59(12). 2104–2107. 44 indexed citations

20.

Lerebours, Guy, J Sénant, Naing Moore, et al.. (1987). Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.. PubMed. 23 Suppl 11. 203s–206s. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact